Briefly and concisely describe:
-
The data that will be generated or collected.
-
The formats and standards that will be used.
-
The value the data may have for other researchers.
-
What data cannot be shared and why.
This page is intended as support to researchers when creating their data management plans. Given that practices vary depending on the discipline and type of project, each beneficiary is responsible for adopting the model that best suits the characteristics and needs if their project. Nonetheless, beneficiaries are hereby informed that they must create the data management plan in accordance with this policy, which requires them to include the following information in the management application of grants to research, scholarships and innovation, in line with this template..
Briefly and concisely describe:
The data that will be generated or collected.
The formats and standards that will be used.
The value the data may have for other researchers.
What data cannot be shared and why.
Indicate which people will be responsible for:
Monitoring the plan.
Managing the data.
Preservation and conservation.
Specify who will decide about access to the data and, in the case of intellectual property, who will own the rights.
Describe what action will be taken to make the data findable, accessible, interoperable and reusable.
Findable data
Indicate which metadata will be used.
Specify which identifier will be used for the data.
Indicate what version control will be undertaken.
Accessibility
Indicate who can access the data and when.
Specify the availability of the data.
Specify which methods or software are necessary to access the data.
Indicate whether documentation on the necessary software is included and, if possible, include it.
Specify where the data, metadata, documentation and code are deposited.
Specify how access is granted in those cases where restrictions are necessary.
Interoperability
describe how interoperability of the data through the use of controlled vocabularies will be facilitated.
Reusability
Specify the degree of reuse permitted when the data are made available to other researchers and the wider public.
Specify when the data will be accessible for reuse. Given the case, specify why and how long the data will be embargoed.
Specify whether the data generated and/or collected in the project are reusable by third parties, above all on conclusion of the project. If data reuse is restricted, explain the reason.
Specify the periods during which the data may be reused.
Data recovery processing, secure storage and transfer of sensitive data: Describe the measures adopted to safeguard data security. This includes storage and security copies, long-term storage and how security and protection of the data will be maintained.
Coverage of the ethics review procedure context: A description must be made of any possible ethical issues in the gathering, retaining, processing or storing of the data, as well as in the ethical approval procedures related to the project.
If the research activities include children, patients, members of a vulnerable population, the use of embryonic stem cells, issues related to privacy or data protection or research on animals and primates, the ethical principles and relevant national, EU and international legislation must be complied with. This is the point in the data management plan where these matters should be addressed.
Indicate any other aspect of interest.
© Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona, ”la Caixa”. All rights reserved.
Programme description
Calls for Applications
Back
Calls for Applications
Calls for Research and Innovation proposals
Back
Calls for Research and Innovation proposals
Information about the calls
CaixaImpulse Health Innovation call
CaixaResearch Health call
Ended calls
Ended calls
At a glance >
CaixaResearch Validate Call >
CaixaResearch Consolidate Call >
CaixaResearch Mobility – Global Medicine and Health call >
CaixaResearch Covid-19 Call >
Call for Mount Sinai Icahn School of Medicine ”la Caixa” Foundation Postdoctoral Fellowships >
Call for MIT-SPAIN ”la Caixa” Foundation SEED FUND >
RecerCaixa call >
Results
Back
Results
CaixaResearch Results
Back
CaixaResearch Results
Keep informed
CaixaResearch DEBATES
CaixaResearch DEBATES
40 years of AIDS. How long before a cure or vaccine? >
Extremely premature babies: increasing their survival >
Pancreatic cancer, new treatments for the deadliest forms of cancer >
Success of treatments now available for COVID-19 patients >
Cancer. What direction are the new therapies taking? >
Women and science, overcoming stereotypes and inequality >
Leukemia, present and future of the new treatments >
New challenges in vaccination and disease eradication >
Can we cure obesity? A 21st century pandemic >
ALS, a fatal disease… for how long? >
How do we approach heart disease? The leading cause of death globally >
Rare diseases: Why is there no treatment for 95% of them? >
COVID-19: how should we live with it? >
Is it possible to create a universal vaccine for chronic infectious diseases? >
Curing blindness: treating the retina to restore vision >
How the brain perceives the world and generates memories >
Cancer and nutrition: The importance of prevention >
Long COVID-19: How much do we know? >
What are CAR-T-cell cancer therapies? >
Can a light-activated drug restore vision or reduce cardiac lesions? >
Parkinson’s: a disease with treatments, but no cure >
Melanoma: the most aggressive skin cancer >
Mosquito-borne infectious diseases: how can we prevent possible outbreaks in Spain? >
One in ten people have dyslexia and most are unaware of it >
Fatty liver disease: an under-diagnosed condition affecting over a third of the population >
Liquid biopsy: can we detect cancer early? >
Artificial intelligence in biomedicine: present and future >
Superbugs: how can we tackle one of the biggest threats to global health? >
Bladder cancer: new advances against one of the most common tumours >
The microbiota-gut-brain axis and its influence on metabolism and health >
The incidence of colon cancer is increasing among young people >
Tuberculosis is still the infectious disease that causes the most deaths >
Organ transplantation: more and better life for the patient. Challenges and advances >
CaixaResearch MEETINGS
CaixaResearch Ceremonies
Innovation Day Portugal
Outstanding results
CaixaResearch Institute